Total Payments
$1.8M
2024 Payments
$248,521
Companies
54
Transactions
3,504
Medicare Patients
1,187
Medicare Billing
$136,098
Payment Breakdown by Category
Other$1.3M (70.8%)
Consulting$276,021 (15.3%)
Travel$200,571 (11.2%)
Food & Beverage$48,548 (2.7%)
Education$72.71 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.2M | 997 | 64.6% |
| Consulting Fee | $276,021 | 144 | 15.3% |
| Travel and Lodging | $200,571 | 994 | 11.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $68,364 | 56 | 3.8% |
| Food and Beverage | $48,548 | 1,283 | 2.7% |
| Honoraria | $21,138 | 6 | 1.2% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $13,800 | 5 | 0.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,725 | 6 | 0.5% |
| Education | $72.71 | 13 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $781,047 | 1,738 | $0 (2024) |
| Novo Nordisk Inc | $299,815 | 372 | $0 (2024) |
| Abbott Laboratories | $237,252 | 415 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $129,805 | 250 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94,567 | 158 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $58,773 | 71 | $0 (2024) |
| Eli Lilly and Company | $42,449 | 26 | $0 (2024) |
| Insulet Corporation | $41,188 | 122 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $22,905 | 65 | $0 (2022) |
| Corcept Therapeutics | $18,622 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248,521 | 408 | Lilly USA, LLC ($86,635) |
| 2023 | $224,748 | 381 | Lilly USA, LLC ($76,810) |
| 2022 | $254,437 | 368 | Lilly USA, LLC ($99,988) |
| 2021 | $186,236 | 308 | Lilly USA, LLC ($100,035) |
| 2020 | $219,702 | 364 | Lilly USA, LLC ($113,523) |
| 2019 | $210,971 | 531 | Lilly USA, LLC ($106,983) |
| 2018 | $214,869 | 529 | Lilly USA, LLC ($92,821) |
| 2017 | $239,196 | 615 | Lilly USA, LLC ($104,253) |
All Payment Transactions
3,504 individual payment records from CMS Open Payments — Page 1 of 141
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Insulet Corporation | Omnipod (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $375.00 | General |
| Category: Insulin Pump | ||||||
| 12/13/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,293.00 | General |
| 12/12/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,293.00 | General |
| 12/12/2024 | Eli Lilly and Company | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $862.00 | General |
| 12/12/2024 | Insulet Corporation | Omnipod (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $335.00 | General |
| Category: Insulin Pump | ||||||
| 12/11/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $787.50 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | Cash or cash equivalent | $124.95 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $78.82 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $174.20 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $147.52 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $5.98 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Diabetes Care | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,325.00 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 264 | 502 | $86,805 | $33,009 |
| 2022 | 8 | 327 | 644 | $106,395 | $39,873 |
| 2021 | 6 | 260 | 453 | $90,897 | $31,831 |
| 2020 | 6 | 336 | 543 | $115,031 | $31,385 |
Total Patients
1,187
Total Services
2,142
Medicare Billing
$136,098
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 190 | $45,410 | $16,881 | 37.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 63 | $20,687 | $8,482 | 41.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 49 | 124 | $7,440 | $3,196 | 43.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $5,027 | $1,841 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,706 | $1,648 | 35.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 61 | 101 | $3,535 | $961.52 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 258 | $61,462 | $21,976 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 63 | $20,223 | $7,970 | 39.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 44 | 130 | $7,734 | $3,355 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,964 | $2,443 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 36 | $5,976 | $2,305 | 38.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 64 | 109 | $1,775 | $1,046 | 59.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 12 | 13 | $845.00 | $411.19 | 48.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 13 | $416.00 | $366.60 | 88.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 186 | $47,416 | $16,003 | 33.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 81 | $27,771 | $9,668 | 34.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 27 | 74 | $4,029 | $2,012 | 49.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $5,244 | $1,788 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 29 | $5,382 | $1,700 | 31.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 48 | 68 | $1,054 | $660.28 | 62.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 150 | 280 | $71,030 | $18,363 | 25.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 38 | 55 | $18,800 | $5,399 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 62 | 73 | $12,566 | $2,949 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $6,396 | $2,829 | 44.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 19 | 45 | $4,806 | $1,219 | 25.4% |
About Dr. Eden Miller, D.O
Dr. Eden Miller, D.O is a Obesity Medicine healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114997988.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eden Miller, D.O has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $248,521 received in 2024. These payments were reported across 3,504 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.2M).
As a Medicare-enrolled provider, Miller has provided services to 1,187 Medicare beneficiaries, totaling 2,142 services with total Medicare billing of $136,098. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Obesity Medicine
- Other Specialties Diabetology
- Location Bend, OR
- Active Since 01/25/2006
- Last Updated 12/30/2025
- Taxonomy Code 207QB0002X
- Entity Type Individual
- NPI Number 1114997988
Products in Payments
- TRULICITY (Drug) $373,801
- JARDIANCE (Drug) $276,635
- INVOKANA (Drug) $129,438
- MOUNJARO (Drug) $114,113
- Ozempic (Drug) $96,865
- FREESTYLE LIBRE 3 (Device) $66,993
- Rybelsus (Drug) $60,822
- Kerendia (Drug) $53,868
- FreeStyle Libre Pro (Device) $49,471
- Omnipod (Device) $41,188
- RYBELSUS (Drug) $37,451
- Xultophy 100/3.6 (Drug) $35,899
- FREESTYLE LIBRE (Device) $31,142
- FreeStyle Libre (Device) $30,400
- Tresiba (Drug) $27,634
- BASAGLAR (Drug) $22,527
- FARXIGA (Drug) $22,476
- Korlym (Drug) $18,622
- BAQSIMI (Drug) $16,270
- FREESTYLE LIBRE 2 (Device) $14,606
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.